This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Grail said Thursday that Bob Ragusa will retire as CEO on June 1 and be replaced by Josh Ofman. Ofman joined Grail in 2019, initially working as chief of corporate strategy and external affairs before a series of promotions culminated in his appointment as the company’s president in 2021.  Ragusa announced his retirement weeks after a trial of Grail’s ...